Evolent Health, Inc. (EVH)
After hours:
| Previous close | 26.96 |
| Open | 26.24 |
| Bid | 24.44 x 900 |
| Ask | 24.29 x 1200 |
| Day's range | 23.87 - 26.67 |
| 52-week range | 23.33 - 35.83 |
| Volume | |
| Avg. volume | 946,900 |
| Market cap | 2.842B |
| Beta (5Y monthly) | 1.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.
Evolent Health, Inc. (NYSE: EVH), a $2 billion revenue company focused on achieving better health outcomes for people with complex conditions, today announced it is partnering with Careology, a digital cancer care platform, to enable more coordinated, connected and empowered journeys for people living with cancer in the U.S.
- PR Newswire
Evolent Announces First Quarter 2024 Results
Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the quarter ended March 31, 2024.
- PR Newswire
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make healthcare simpler and more affordable, today announced it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after market close, with a conference call to follow at 5 p.m. ET.
